HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Taniguchi Selected Research

Peptides (Polypeptides)

4/2007Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
11/2000Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Taniguchi Research Topics

Disease

22Neoplasms (Cancer)
07/2020 - 03/2000
8Stomach Neoplasms (Stomach Cancer)
02/2015 - 11/2000
7Neoplasm Metastasis (Metastasis)
07/2020 - 04/2000
5Infections
08/2015 - 08/2001
5Breast Neoplasms (Breast Cancer)
12/2010 - 08/2000
4Disease Progression
01/2018 - 12/2001
4Idiopathic Pulmonary Fibrosis
11/2010 - 11/2000
4Inflammation (Inflammations)
11/2001 - 11/2000
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2018
3Asthma (Bronchial Asthma)
02/2012 - 11/2001
3Hepatocellular Carcinoma (Hepatoma)
11/2002 - 03/2001
3Chlamydophila Infections
11/2001 - 09/2001
3Eosinophilia
08/2001 - 11/2000
2Prostatic Neoplasms (Prostate Cancer)
07/2020 - 01/2016
2Carcinoma (Carcinomatosis)
10/2018 - 07/2010
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2017 - 10/2015
2Lymphopenia (Lymphocytopenia)
11/2017 - 10/2015
2Pain (Aches)
04/2016 - 10/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2013 - 11/2011
2Fibrosis (Cirrhosis)
12/2007 - 01/2000
2Colonic Neoplasms (Colon Cancer)
10/2007 - 04/2000
2Interstitial Lung Diseases (Interstitial Lung Disease)
03/2005 - 11/2000
2Thrombosis (Thrombus)
12/2004 - 03/2001
2Type 2 Diabetes Mellitus (MODY)
01/2004 - 08/2001
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2004 - 06/2000
2Paragonimiasis
12/2001 - 01/2001
2Empyema
08/2001 - 01/2001
2Acute Liver Failure (Fulminant Hepatic Failure)
06/2001 - 11/2000
2Body Weight (Weight, Body)
04/2001 - 10/2000
2Tuberculosis (Tuberculoses)
01/2001 - 09/2000
2Lymphatic Metastasis
11/2000 - 03/2000
1Metabolic Bone Diseases (Osteopenia)
07/2020
1Microsatellite Instability
01/2020
1Fatigue
01/2018
1Adenocarcinoma
01/2018
1Sarcopenia
03/2017
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2016
1Hypoxia (Hypoxemia)
01/2016
1Encephalitis (Encephalitis, Rasmussen)
08/2015

Drug/Important Bio-Agent (IBA)

5EnzymesIBA
02/2015 - 09/2000
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2010 - 03/2001
3Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2007
3Biomarkers (Surrogate Marker)IBA
01/2020 - 11/2011
3Indicators and Reagents (Reagents)IBA
11/2010 - 09/2000
3Carcinoembryonic AntigenIBA
12/2007 - 01/2001
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2005 - 09/2000
3ImmunosorbentsIBA
10/2002 - 11/2000
3InterleukinsIBA
12/2001 - 11/2000
3Pamidronate (Aredia)FDA LinkGeneric
11/2001 - 08/2000
3Interleukin-5 (Interleukin 5)IBA
08/2001 - 11/2000
2AndrogensIBA
07/2020 - 01/2016
2Bendamustine HydrochlorideFDA Link
11/2017 - 10/2015
2Small Interfering RNA (siRNA)IBA
02/2015 - 10/2007
2montelukast (Singulair)FDA Link
02/2012 - 08/2002
2Peptides (Polypeptides)IBA
04/2007 - 11/2000
2Prednisolone (Predate)FDA LinkGeneric
03/2005 - 08/2001
2AntigensIBA
12/2001 - 01/2001
2Paclitaxel (Taxol)FDA LinkGeneric
11/2001 - 11/2001
2FadrozoleIBA
11/2001 - 08/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2001 - 09/2000
2TamoxifenFDA LinkGeneric
11/2001 - 08/2000
2doxifluridineIBA
11/2001 - 08/2000
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2001 - 11/2000
1YM 529IBA
07/2020
1DenosumabFDA Link
07/2020
1Hormones (Hormone)IBA
07/2020
1Retinoblastoma ProteinIBA
07/2020
1Positive Regulatory Domain I-Binding Factor 1IBA
07/2020
1MineralsIBA
07/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1pembrolizumabIBA
01/2020
1entrectinibIBA
01/2020
1larotrectinibIBA
01/2020
1TropomyosinIBA
01/2020
1PlatinumIBA
10/2018
1nintedanibIBA
01/2018
1eribulinFDA Link
01/2018
1Triglycerides (Triacylglycerol)IBA
03/2017
1Rituximab (Mabthera)FDA Link
09/2016
1Analgesics (Analgesic Drugs)IBA
04/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2016
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
01/2016
1Explosive Agents (Explosives)IBA
12/2015
1Untranslated Regions (Untranslated Region)IBA
12/2015

Therapy/Procedure

18Therapeutics
01/2018 - 04/2000
7Drug Therapy (Chemotherapy)
10/2018 - 04/2000
4Transplantation
03/2017 - 05/2014
4Gastrectomy
07/2010 - 03/2000
3Neoadjuvant Therapy
11/2001 - 04/2000
2Combination Drug Therapy (Combination Chemotherapy)
10/2018 - 11/2001
2Radiotherapy
01/2018 - 03/2000
2Mechanical Ventilators (Ventilator)
11/2011 - 10/2000
2Autologous Blood Transfusion
09/2001 - 05/2001
2Liver Transplantation
08/2001 - 11/2000
1Subcutaneous Injections
07/2020
1Immunotherapy
01/2020
1Kidney Transplantation
03/2017
1Hematopoietic Stem Cell Transplantation
08/2015